These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 26729950

  • 1. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S, Mohanty M, Padhan P.
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [Abstract] [Full Text] [Related]

  • 2. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F, Ciapetti A, Gasparini S, Carotti M, Bombardieri S, New Indices study group.
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [Abstract] [Full Text] [Related]

  • 3. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
    McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, Capell HA, Sattar N.
    Lancet; 2004 Jun 19; 363(9426):2015-21. PubMed ID: 15207950
    [Abstract] [Full Text] [Related]

  • 4. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.
    Scand J Rheumatol; 2016 Jul 19; 45(4):274-81. PubMed ID: 26767827
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A, Poil AR, Hammoudeh M.
    Int J Rheum Dis; 2014 Jan 19; 17(1):63-5. PubMed ID: 24472269
    [Abstract] [Full Text] [Related]

  • 6. The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis.
    Lv S, Liu Y, Zou Z, Li F, Zhao S, Shi R, Bian R, Tian H.
    Clin Exp Rheumatol; 2015 Jan 19; 33(1):69-76. PubMed ID: 25327393
    [Abstract] [Full Text] [Related]

  • 7. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C, Ribeiro AC, Fabri GM, Calich AL, Carvalho J, Silva CA, Viana VS, Bonfá E, Siqueira JT.
    J Clin Rheumatol; 2012 Jun 19; 18(4):180-4. PubMed ID: 22647860
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM, Kim SY, Lee SH, Yang CM, Seo YI, Kim HA.
    Int J Rheum Dis; 2016 Dec 19; 19(12):1278-1283. PubMed ID: 26200604
    [Abstract] [Full Text] [Related]

  • 9. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.
    Ann Rheum Dis; 2010 Jul 19; 69(7):1378-82. PubMed ID: 19919943
    [Abstract] [Full Text] [Related]

  • 10. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, Yasuda M, Saisho K, Shimada K, Tohma S.
    Ann Rheum Dis; 2007 Sep 19; 66(9):1221-6. PubMed ID: 17369281
    [Abstract] [Full Text] [Related]

  • 11. A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients.
    Hegazy SK, El-Ghany El-Sayed Sel-M, El-Hefnawy Mel-S.
    J Clin Pharmacol; 2016 Oct 19; 56(10):1272-6. PubMed ID: 26899523
    [Abstract] [Full Text] [Related]

  • 12. Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.
    Ajeganova S, van Steenbergen HW, van Nies JA, Burgers LE, Huizinga TW, van der Helm-van Mil AH.
    Ann Rheum Dis; 2016 May 19; 75(5):867-73. PubMed ID: 25972519
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I, Akcay-Yalbuzdag S, Ince B, Goksel-Karatepe A, Kaya T.
    Int J Rheum Dis; 2015 Jul 19; 18(6):640-5. PubMed ID: 26013310
    [Abstract] [Full Text] [Related]

  • 14. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH, Furst G, Yarboro C, el-Gabalawy H.
    Clin Exp Rheumatol; 2003 Jul 19; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [Abstract] [Full Text] [Related]

  • 15. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
    Tymms K, Zochling J, Scott J, Bird P, Burnet S, de Jager J, Griffiths H, Nicholls D, Roberts L, Arnold M, Littlejohn G.
    Arthritis Care Res (Hoboken); 2014 Feb 19; 66(2):190-6. PubMed ID: 23983001
    [Abstract] [Full Text] [Related]

  • 16. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
    Ozen G, Pedro S, Holmqvist ME, Avery M, Wolfe F, Michaud K.
    Ann Rheum Dis; 2017 May 19; 76(5):848-854. PubMed ID: 27836820
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis.
    Ren C, Li M.
    Medicine (Baltimore); 2023 Sep 15; 102(37):e35088. PubMed ID: 37713899
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
    Drosos AA, Voulgari PV, Papadopoulos IA, Politi EN, Georgiou PE, Zikou AK.
    Clin Exp Rheumatol; 1998 Sep 15; 16(6):695-701. PubMed ID: 9844762
    [Abstract] [Full Text] [Related]

  • 19. Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysis.
    Xing B, Yin YF, Zhao LD, Wang L, Zheng WJ, Chen H, Wu QJ, Tang FL, Zhang FC, Shan G, Zhang X.
    Medicine (Baltimore); 2015 Feb 15; 94(8):e572. PubMed ID: 25715256
    [Abstract] [Full Text] [Related]

  • 20. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug 15; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.